Document is current
Any future updates will be listed below
-
Authors
de Rouw, Nikki https://orcid.org/0000-0002-1991-0552
Piet, Berber
Derijks, Hieronymus J.
van den Heuvel, Michel M.
ter Heine, Rob
-
Funding
Funding for this research was provided by:
zonmw (848016010)
- License Information
-
More Information
Article History
Accepted: 21 October 2021
First Online: 6 November 2021
Declarations
:
: This research was supported by ZonMw, The Netherlands (Grant number: 848016010).
: Drs. Nikki de Rouw, Dr. Hieronymus J. Derijks, Prof. Dr. Michel M. van den Heuvel and Dr. Rob ter Heine have nothing to disclose. Dr. Berber Piet reports membership of Advisory Boards of Takeda and Bristol Meyer Squibb and lecturer fees from Astra Zeneca and Pfizer, outside the submitted work.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Manuscript writing, editing, and revisions: Drs. Nikki de Rouw, Dr. Berber Piet, Dr. Hieronymus J. Derijks, Prof. Dr. Michel M. van den Heuvel, and Dr. Rob ter Heine. All authors read and approved the final version.
